Royalty Pharma PLC

Royalty Pharma declares $0.235 dividend

Seeking Alpha · 3 d ago

Royalty Pharma plc (RPRX) Declares $0.235 Q4 Dividend

TradingView · 3 d ago

Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug

Reuters · 4 d ago

Royalty Pharma to announce third quarter 2026 financial results on November 4, 2026

GlobeNewswire · 10 d ago

Royalty Pharma Is Maintained at Overweight by Morgan Stanley

Dow Jones Newswires · 12 d ago

Royalty Pharma announces $7.5 million gift to Blood Cancer United to expand Therapy Acceleration Program

globenewswire · 34 d ago

Notable healthcare headlines for the week: UnitedHealth, Amgen, and CooperCompanies in focus

seekingalpha · 36 d ago

Royalty Pharma to present at upcoming investor conferences

globenewswire · 40 d ago

Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen

globenewswire · 45 d ago

Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million

GlobeNewsWire · 68 d ago

Royalty Pharma reports second quarter 2026 results

GlobeNewsWire · 75 d ago

Royalty Pharma appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives

GlobeNewsWire · 77 d ago